CONTINUE TO SITE
OR WAIT null SECS
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
New Delivery Option for Ketamine
How can new formulations of ketamine impact patient care?
Jeffrey Becker, MD, discusses new formulations of ketamine for subcutaneous delivery and how ketamine works.
Dr Becker is cofounder and Chief Scientific Officer at Bexson Biomedical, Inc.